4222 Emperor Boulevard, Suite 460 Durham, NC 27703

tel: (919) 993-3389 fax: (919) 991-1910

www.briworldwide.com
Media Contact:
Amanda Frasca
Howard/Merrell
(919) 844-2746
afrasca@howardmerrell.com


FOR IMMEDIATE RELEASE



BRI Expands Enzyme Research and Development Credentials


Research Triangle Park, N.C.February 7, 2014BioResource International, Inc. (BRI), an
agricultural biotechnology company specializing in the research and development of enzymes,
has been awarded another US patent. With the new patent, the company expands its intellectual
property portfolio in enzyme technology to include the use of its proprietary protease feed
additive in both poultry and swine diets. This patent allows us to expand our reach into the
swine market where this enzyme demonstrates an equally strong value proposition, said CEO
Giles Shih. The companys first product, Versazyme, has become the leading protease enzyme
in poultry feed as a result of consistent premium performance demonstrated in the field.

The success of our protease enzyme continues to fuel our growth and has built a foundation
upon which to expand our portfolio of feed enzyme solutions, added CEO Giles Shih. We are
in the process of introducing to the market another proprietary, premium performance enzyme,
this time, a xylanase. We are very pleased with the high level of interest in this new product
during last weeks IPPE conference in Atlanta, GA.

BRI has also expanded the expertise of its research and development team with the addition of
Dr. Sanjeewa Rupasinghe in the position of Research Scientist. Dr. Rupasinghe is a protein
biochemist-enzymologist with a BS in Biology from the University of Colombo and a PhD from
the University of Illinois. A published scientist, Dr. Rupasinghe has over ten years of industrial
and academic experience in enzymology, enzyme characterization and engineering and protein


4222 Emperor Boulevard, Suite 460 Durham, NC 27703
tel: (919) 993-3389 fax: (919) 991-1910
www.briworldwide.com
expression and analysis. His background includes a post-doctoral fellowship at Pfizer, Inc. where
he researched and engineered enzymes for industrial scale processes.

We are most excited to welcome Sanjeewa to our technology team, said Dr. JJ Wang, CTO
and Senior VP of Research and Development. His experience and skills are an excellent
complement to those of the rest of our team members and will prove invaluable as we continue
to develop innovative, sustainable solutions that help to feed the growing world population.


About BioResource International, Inc.
BRI is a biotechnology company that is harnessing the natural power of enzymes to develop
sustainable solutions that help feed the world. Through the discovery and development of
innovative animal feed enzymes, BRI hopes to create a future for animal agriculture that is both
economically and environmentally sustainable from farm to fork. Founded by father and son
team Jason and Giles Shih, BRI has developed two products, Versazyme and Valkerase,
which are distributed to more than 80 countries worldwide. BRI continues to research science-
based solutions to aid growing agricultural and industrial markets around the world. For more
information, visit www.briworldwide.com.


# # #